Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 44 |
|
|||||
| News | - |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bone Biologics Corporation | BBLGW | NASDAQ | Equity Warrant |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 20.20 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.00 | 12.00 | 12.00 | 20.20 | 20.20 |
| Trades | Volume | Avg Volume |
|---|---|---|
| 9 | 44 | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:55:11 | 6 | 15.21 | USD |
Bone Biologics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 63.31M | 3.13M | - | 0 | -8.95M | -2.86 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Bone Biologics
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Edgar (US Regulatory) •
Wed Feb 26, 2025 5:00 PM (3 weeks ago)
Form 4 - Statement of changes in beneficial ownership of securities Edgar (US Regulatory) •
Tue Jan 21, 2025 6:10 AM (2 months ago)
Form 4 - Statement of changes in beneficial ownership of securities Edgar (US Regulatory) •
Tue Jan 21, 2025 6:06 AM (2 months ago)
Form 8-K - Current report Edgar (US Regulatory) •
Fri Dec 13, 2024 5:05 PM (3 months ago)
Form 424B5 - Prospectus [Rule 424(b)(5)] Edgar (US Regulatory) •
Fri Dec 13, 2024 5:00 PM (3 months ago)
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] Edgar (US Regulatory) •
Thu Nov 14, 2024 7:19 PM (4 months ago)
Form 10-Q - Quarterly report [Sections 13 or 15(d)] Edgar (US Regulatory) •
Thu Nov 14, 2024 5:00 PM (4 months ago)
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] Edgar (US Regulatory) •
Wed Nov 13, 2024 11:14 AM (4 months ago)
Form 8-K - Current report Edgar (US Regulatory) •
Mon Oct 21, 2024 8:05 AM (5 months ago)
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors Business Wire •
Mon Oct 21, 2024 8:00 AM (5 months ago)
Form 4 - Statement of changes in beneficial ownership of securities Edgar (US Regulatory) •
Fri Oct 18, 2024 8:27 PM (5 months ago)
Form 3 - Initial statement of beneficial ownership of securities Edgar (US Regulatory) •
Fri Oct 18, 2024 8:25 PM (5 months ago)
BBLGW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. |
NASDAQ:BBLGW -
What is the current Bone Biologics Corporation share price?
The current share price of Bone Biologics Corporation is $ 20.20
How many Bone Biologics Corporation shares are in issue?
Bone Biologics Corporation has 3,134,000 shares in issue
What is the market cap of Bone Biologics Corporation?
The market capitalisation of Bone Biologics Corporation is USD 63.31M
What is the 1 year trading range for Bone Biologics Corporation share price?
Bone Biologics Corporation has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Bone Biologics Corporation?
The price to earnings ratio of Bone Biologics Corporation is -0.3
What is the reporting currency for Bone Biologics Corporation?
Bone Biologics Corporation reports financial results in USD
What is the latest annual profit for Bone Biologics Corporation?
The latest annual profit of Bone Biologics Corporation is USD -8.95M
What is the registered address of Bone Biologics Corporation?
The registered address for Bone Biologics Corporation is 1013 CENTRE ROAD, SUITE 403-B, NEW CASTLE, WILMINGTON, DELAWARE, 19805
What is the Bone Biologics Corporation website address?
The website address for Bone Biologics Corporation is www.bonebiologics.com
Which industry sector does Bone Biologics Corporation operate in?
Bone Biologics Corporation operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector
